Oxyimperatorin Suppresses the Pathologies of Rheumatoid Arthritis and the Growth of Synovial Organoids Through Targeting the PI3K / AKT Pathway

Fuente: Wiley Open Access
Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Xu Gao, Shuyan Lyu, Tengyu Lin, Juan He, Weiye Pan, Jiaxin He, Xiaocheng Wang, Xian Lin, Jian Chen, Qingwen Wang
Format: Artículo Open Access
Veröffentlicht: Wiley 2025
Schlagworte:
Online-Zugang:
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
_version_ 1867004327117193217
author Xu Gao
Shuyan Lyu
Tengyu Lin
Juan He
Weiye Pan
Jiaxin He
Xiaocheng Wang
Xian Lin
Jian Chen
Qingwen Wang
author_facet Xu Gao
Shuyan Lyu
Tengyu Lin
Juan He
Weiye Pan
Jiaxin He
Xiaocheng Wang
Xian Lin
Jian Chen
Qingwen Wang
Xu Gao
Shuyan Lyu
Tengyu Lin
Juan He
Weiye Pan
Jiaxin He
Xiaocheng Wang
Xian Lin
Jian Chen
Qingwen Wang
collection Wiley Open Access
contents Oxyimperatorin Suppresses the Pathologies of Rheumatoid Arthritis and the Growth of Synovial Organoids Through Targeting the PI3K / AKT Pathway Xu Gao Shuyan Lyu Tengyu Lin Juan He Weiye Pan Jiaxin He Xiaocheng Wang Xian Lin Jian Chen Qingwen Wang Phytotherapy Research ABSTRACT Oxyimperatorin (OIMP) is a coumarin extracted from the roots of the traditional Chinese medicinal plant Bai Zhi ( Angelica dahurica ). This study aimed to investigate the potential effects and underlying mechanisms of OIMP in the progression of rheumatoid arthritis (RA). CCK‐8, immunofluorescence, flow cytometry, and EdU assays were performed to evaluate the effects of OIMP on the functions of RA fibroblast‐like synoviocytes (RA‐FLSs). RNA sequencing (RNA‐seq), quantitative real‐time PCR (RT‐qPCR), Western blot, kinase assay, and network pharmacological analysis were conducted to elucidate the mechanism of action of OIMP in RA. OIMP inhibited the proliferation of RA‐FLSs by suppressing DNA replication and inducing cell cycle arrest. It also promoted the apoptosis and impaired the migratory and invasive capabilities of RA‐FLSs. Moreover, OIMP disrupted the cell cycle by downregulating the mRNA and protein levels of cyclin B1 and cyclin‐dependent kinase 1 (CDK1), and promoted apoptosis by reducing survivin expression and inducing DNA damage. In vivo, OIMP suppressed synovial organoid growth and alleviated symptoms in collagen‐induced arthritis (CIA) mice. RNA‐seq and Western blot further confirmed that OIMP inhibited the phosphoinositide 3‐kinase (PI3K)/protein kinase B (AKT) signaling axis. Network pharmacological analysis suggested a pivotal role of the PI3K/AKT pathway in mediating OIMP's effects in RA. Additionally, OIMP was shown to bind to AKT1. In conclusion, OIMP may act as a potential AKT1 inhibitor that suppresses the pathologies of RA through targeting the PI3K/AKT pathway. 10.1002/ptr.70009 http://onlinelibrary.wiley.com/termsAndConditions#vor
doi_str_mv 10.1002/ptr.70009
format Artículo Open Access
id wiley_oa_10_1002_ptr_70009
institution Wiley Open Access
license_str_mv http://onlinelibrary.wiley.com/termsAndConditions#vor
publishDate 2025
publisher Wiley
record_format wiley_oa
spellingShingle Oxyimperatorin Suppresses the Pathologies of Rheumatoid Arthritis and the Growth of Synovial Organoids Through Targeting the PI3K / AKT Pathway
Xu Gao
Shuyan Lyu
Tengyu Lin
Juan He
Weiye Pan
Jiaxin He
Xiaocheng Wang
Xian Lin
Jian Chen
Qingwen Wang
Phytotherapy Research
Oxyimperatorin Suppresses the Pathologies of Rheumatoid Arthritis and the Growth of Synovial Organoids Through Targeting the PI3K / AKT Pathway Xu Gao Shuyan Lyu Tengyu Lin Juan He Weiye Pan Jiaxin He Xiaocheng Wang Xian Lin Jian Chen Qingwen Wang Phytotherapy Research ABSTRACT Oxyimperatorin (OIMP) is a coumarin extracted from the roots of the traditional Chinese medicinal plant Bai Zhi ( Angelica dahurica ). This study aimed to investigate the potential effects and underlying mechanisms of OIMP in the progression of rheumatoid arthritis (RA). CCK‐8, immunofluorescence, flow cytometry, and EdU assays were performed to evaluate the effects of OIMP on the functions of RA fibroblast‐like synoviocytes (RA‐FLSs). RNA sequencing (RNA‐seq), quantitative real‐time PCR (RT‐qPCR), Western blot, kinase assay, and network pharmacological analysis were conducted to elucidate the mechanism of action of OIMP in RA. OIMP inhibited the proliferation of RA‐FLSs by suppressing DNA replication and inducing cell cycle arrest. It also promoted the apoptosis and impaired the migratory and invasive capabilities of RA‐FLSs. Moreover, OIMP disrupted the cell cycle by downregulating the mRNA and protein levels of cyclin B1 and cyclin‐dependent kinase 1 (CDK1), and promoted apoptosis by reducing survivin expression and inducing DNA damage. In vivo, OIMP suppressed synovial organoid growth and alleviated symptoms in collagen‐induced arthritis (CIA) mice. RNA‐seq and Western blot further confirmed that OIMP inhibited the phosphoinositide 3‐kinase (PI3K)/protein kinase B (AKT) signaling axis. Network pharmacological analysis suggested a pivotal role of the PI3K/AKT pathway in mediating OIMP's effects in RA. Additionally, OIMP was shown to bind to AKT1. In conclusion, OIMP may act as a potential AKT1 inhibitor that suppresses the pathologies of RA through targeting the PI3K/AKT pathway. 10.1002/ptr.70009 http://onlinelibrary.wiley.com/termsAndConditions#vor
title Oxyimperatorin Suppresses the Pathologies of Rheumatoid Arthritis and the Growth of Synovial Organoids Through Targeting the PI3K / AKT Pathway
topic Phytotherapy Research
url https://onlinelibrary.wiley.com/doi/10.1002/ptr.70009